131 devices · GMDN 30518
Benzodiazepine rapid ICT kits are point-of-care or lab-based diagnostic tools designed to quickly detect benzodiazepines in clinical samples like urine or blood. These tests use immunochromatography to provide results faster than traditional lab methods, often within minutes, supporting urgent clinical decisions such as overdose assessment or drug monitoring.
These devices are typically regulated as in vitro diagnostics (IVDs) and may require compliance with standards like ISO 13485 or CE marking in the EU, depending on jurisdiction. They are usually supplied as kits containing reagents, controls, and instructions for single-use in clinical or pre-hospital settings, ensuring accuracy and traceability in rapid testing scenarios.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.